New treatments offer better survival and fresh challenges in colorectal cancer
Friday, August 21, 2009 - 11:14
in Health & Medicine
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer patients. Now the discovery of genetic biomarkers relevant to CRC means that targeted personalised medication is increasingly common.